M'S Science Corporation
Records under this name other than patents M'S Science Corporation holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 7 of 7 · Back to M'S Science Corporation
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,264,814 | Methods and compositions for producing morphogen analogs Formerly held Term ended Term ended Jan 8, 2023 · High confidence | Term ended | Term ended Jan 8, 2023 | High confidence |
| US 8,183,374 | Piperidine and piperazine derivatives Lapsed on the fee record Ended May 22, 2016 · USPTO record | Lapsed on the fee record | Ended May 22, 2016 | USPTO record |
| US 8,071,602 | Piperidine and piperazine derivatives Lapsed on the fee record Ended Dec 6, 2015 · USPTO record | Lapsed on the fee record | Ended Dec 6, 2015 | USPTO record |
| US 7,985,751 | Piperazine derivatives Lapsed on the fee record Ended Jul 26, 2015 · USPTO record | Lapsed on the fee record | Ended Jul 26, 2015 | USPTO record |
| US 7,863,272 | Sigma Ligands for Neuronal Regeneration and Functional Recovery Lapsed on the fee record Ended Jan 4, 2015 · High confidence | Lapsed on the fee record | Ended Jan 4, 2015 | High confidence |
| US 7,829,562 | Sigma Ligands for Neuronal Regeneration and Functional Recovery Lapsed on the fee record Ended Nov 9, 2014 · High confidence | Lapsed on the fee record | Ended Nov 9, 2014 | High confidence |
| US 5,736,546 | 1,4-(Diphenlyalkyl) piperazine derivatives Term ended Term ended no later than Apr 7, 2018 · Low confidence | Term ended | Term ended no later than Apr 7, 2018 | Low confidence |